Acadia Healthcare (NASDAQ:ACHC) Reaches New 12-Month Low – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) hit a new 52-week low on Thursday . The stock traded as low as $43.58 and last traded at $44.04, with a volume of 138689 shares traded. The stock had previously closed at $52.08.

Analyst Ratings Changes

ACHC has been the topic of a number of recent research reports. KeyCorp started coverage on Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Barclays reduced their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday, September 30th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Friday, September 20th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company. According to MarketBeat, Acadia Healthcare has a consensus rating of “Hold” and an average price target of $86.67.

Acadia Healthcare Stock Performance

The company has a fifty day moving average price of $65.72 and a two-hundred day moving average price of $67.79. The firm has a market cap of $3.90 billion, a price-to-earnings ratio of 13.78, a price-to-earnings-growth ratio of 1.50 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.18 and a quick ratio of 1.18.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The company had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.28%. Acadia Healthcare’s revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.91 EPS. As a group, equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ACHC. Point72 Asset Management L.P. boosted its stake in shares of Acadia Healthcare by 266.0% during the 2nd quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after acquiring an additional 1,650,040 shares in the last quarter. Millennium Management LLC boosted its position in shares of Acadia Healthcare by 3,067.8% in the 2nd quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after purchasing an additional 1,055,894 shares during the period. William Blair Investment Management LLC increased its position in shares of Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after acquiring an additional 604,070 shares in the last quarter. Vaughan Nelson Investment Management L.P. lifted its position in shares of Acadia Healthcare by 67.9% in the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 733,505 shares of the company’s stock valued at $49,541,000 after acquiring an additional 296,625 shares in the last quarter. Finally, Clearline Capital LP acquired a new position in Acadia Healthcare in the 2nd quarter worth approximately $11,179,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.